|
Depakine®
Depakine®
(sodium valproate) is a broad-spectrum treatment for
all types of epileptic attacks and syndromes,
including absence seizure, myoclonic seizure, tonic
clonic seizure, astatic seizures, mixed pattern, west
and lennox Gastaut syndromes. It is also indicated
for the treatment of bipolar disorder. Depakine®
is available in a wide range of formulations,
including oral solution, injection, prolonged
release tablets, to meet with the patients' needs.
Stilnox®
(zolpidem)
Stilnox®
is a non-benzodiazepine hypnotic indicated
for short-term treatment of insomnia.
Stilnox®
is quick to act and produces a quality of
sleep that is close to natural sleep without the
side effects which generally characterize hypnotics.
Perenan®
(codergocrine mesylate)
Perenan® is a novel slow released agent for treating behavioural and psychological disorders including symptoms & signs of mental deterioration, acute cerebrovascular disease, peripheral vascular disorders as well as subjective symptoms associated with arterial hypertension.
|